⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

ARS Pharmaceuticals, Inc. Common Stock

$4.02
-0.04 (-0.86%)

Volume:

2.324M ($9.32M)

Market Capitalization:

$399.78M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

ARS Pharmaceuticals Market Segments

Overnight

*No Trades in Segment

After Hours

+0.00(+0.00%)
Open$4.02
Close$4.02
Low$4.02
Low Change0.00 (0.00%)
High$4.02
High Change+0.00 (+0.00%)
Range$0.00
Volume262.918K
Dollar Volume$1.06M

Regular Trading Hours

-0.07(-1.72%)
Open$4.08
Close$4.01
Low$3.81
Low Change-0.27 (-6.62%)
High$4.08
High Change+0.00 (+0.00%)
Range$0.27
Volume2.061M
Dollar Volume$8.27M

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$4.07
Close$4.07
Low$4.07
Low Change0.00 (0.00%)
High$4.07
High Change+0.00 (+0.00%)
Range$0.00
Volume206.932K
Dollar Volume$842.21K

Regular Trading Hours Yesterday

+0.07(+1.63%)
Open$3.99
Close$4.06
Low$3.94
Low Change-0.05 (-1.25%)
High$4.10
High Change+0.11 (+2.63%)
Range$0.16
Volume1.754M
Dollar Volume$7.11M

Premarket Yesterday

*No Trades in Segment

ARS Pharmaceuticals Top Trades

ARS Pharmaceuticals's top trade so far today returned +5.51%, while the top short trade returned -6.62%.

ARS Pharmaceuticals Moving Averages

5 Day Moving Average (SMA5)$4.09
10 Day Moving Average (SMA10)$4.20
20 Day Moving Average (SMA20)$4.22
50 Day Moving Average (SMA50)$5.02
100 Day Moving Average (SMA100)$6.50
200 Day Moving Average (SMA200)$7.81

ARS Pharmaceuticals Statistics

Average Volume (30 Days)1.46M
P/E Ratio (Current)-1.96
EPS (Current)-$2.16
Dividend Yield0.00%
Free Cash Flow-$196.60M
Cash Ratio0.13
Current Ratio3.48
Quick Ratio3.28
Debt to Equity13.72
Enterprise Value$584.10M
EV to EBITDA-2.72
EV to Sales5.00
Price to Book33.62
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales3.60
Return on Assets-0.86%
Return on Equity-17.20%

ARS Pharmaceuticals Stock Splits

There have been no stock splits for ARS Pharmaceuticals (SPRY).

ARS Pharmaceuticals Dividends

There have been no dividends for ARS Pharmaceuticals (SPRY).